Microsphere: A novel drug delivery system

Colloids in Drug Delivery

Volumn , Issue , 2016, Pages 455-478

  Samad, Abdus ^a   Tariq, Mohammad ^a   Alam, Mohammed Intakhab ^a   Akhter, M S ^b  

^a HAMDARD UNIVERSITY   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY SYSTEM;

DRUG DELIVERY;

EID: 85051151395     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Adriane, K., Huang, J., Ding, G., Chen, J., and Liu, Y. 2006. Self assembled magnetic PVP/PVA hydrogel microspheres: Magnetic drug targeting of VX2 auricular tumours using pingyangmycin. J. Drug Target., 14: 243-253.
2. Akiyama, Y., Nagahara, N., Nara, E., Kitano, M., Iwasa, S., Yamamoto, I., Azuma, J., and Ogawa, Y. 1998. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J. Pharm. Pharmacol., 50: 159-166.
3. Akiyama, Y., Yoshioka, M., Horibe, H., Inada, Y., Hirai, S., Kitamori, N., and Toguchi, H. 1994. Antihypertensive effect of oral controlled release microspheres containing an ACE inhibitor (Delapril hydrochloride) in rats. J. Pharm. Pharmacol., 46: 661-665.
4. Akiyama, Y. and Nagahara, N. 1999. Novel formulation approaches to oral mucoadhesive drug delivery systems. In E. Mathiowitz, D.E. Chickering, and C.M. Lehr (Eds.), Bioadhesive Drug Delivery Systems-Fundamentals, Novel Approaches and Development (pp. 477-505). New York, Marcel Dekker.
5. Bedi, S., Baidya, S., Ghosh, L.K., and Gupta, B.K. 1999. Design and biopharmaceutical evaluation of nitrofurantoin-loaded Eudragit RS100 micropellets. Drug Dev. Ind. Pharm., 25: 937-944.
6. Bernkop-Schnurch, A.S. and Dundalek, K. 1996. Novel bioadesive drug delivery system protecting (poly) peptides from gastric enzymatic degradation. Int. J. Pharm., 138: 75-83.
7. Bogataj, M., Mrhar, A., and Korosec, L. 1999. Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. Int. J. Pharm., 177: 211-220.
8. Budhian, A., Siegel, S.J., and Winey, K.I. 2007. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int. J. Pharm., 36: 367-375.
9. Carino, P.G., Jacob, J.S., Chen, C.J., Santos, C.A., Hertzog, B.A., and Mathiowitz, E. 1999. Bioadhesive, bioerodible polymers for increased intestinal uptake. In E. Mathiowitz, D.E. Chickering, and C.M. Lehr (Eds.), Bioadhesive Drug Delivery Systems-Fundamentals, Novel Approaches and Development (pp. 459-475). New York, Marcel Dekker.
10. Chaurasia, M., Chourasia, M.K., Jain, N.K., Jain, A., Soni, V., Gupta, Y., and Jain, S.K. 2008. Methotrexate bearing calcium pectinate microspheres: A platform to achieve colon-specific drug release. Curr. Drug Deliv., 5: 215-219.
11. Choy, Y.B., Park, J.H., McCarey, B.E., Edelhauser, H.F., and Prausnitz, M.R. 2008. Mucoadhesive microdiscs engineered for ophthalmic drug delivery: Effect of particle geometry and formulation on preocular residence time. Invest. Ophthalmol. Vis. Sci., 29: 34-78.
12. Coowanitwong, I., Arya, V., Kulvanich, P., and Hochhaus, G. 2008. Slow release formulations of inhaled rifampin. AAPS J., 10: 342-348.
13. Costa, P. and Lobo, J.M.S. 2001. Modeling and comparison of dissolution. Eur. J. Pharm., 13: 123-133.
14. Duchene, D., Wouessidjewe, D., and Ponchel, G. 1999. Cyclodextrins and carrier systems. J. Control. Release, 62: 263-268.
15. Dutt, M. and Khuller, G.K. 2000. Poly (dl-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin. Indian J. Exp. Biol., 38: 887-894.
16. Farraj, N.F., Johansen, B.R., Davis, S.S., and Illum, L. 1990. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Control. Release, 13: 253-261.
17. Gao, Y., Cui, F.D., Guan, Y., Yang, L., Wang, Y. S., and Zhang, L.N. 2006. Preparation of roxithromycinpolymeric microspheres by the emulsion solvent diffusion method for taste masking. Int. J. Pharm., 318:62-69.
18. Gaskell, E.E., Hobbs, G., Rostron, C., and Hutcheon, G.A. 2008. Encapsulation and release of alphachymotrypsin from poly (glycerol adipate-co-omega-pentadecalactone) microparticles. J. Microencapsul., 25: 187-195.
19. Gavini, E., Hegge, A.B., Rassu, G., Sanna, V., Testa, C., Pirisino, G., Karlsen, J., and Giunchedi, P. 2006. Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int. J. Pharm., 307: 9-15.
20. Gavini, E., Sanna, V., Juliano, C., Bonferoni, M.C., and Giunchedi, P. 2002. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech, 3(3): 20-25.
21. Geary, S. and Schlameus, H.W. 1993. Vancomycin and insulin used as models for oral delivery of peptides. J. Control. Release, 23: 65-74.
22. Genta, I., Conti, B., Perugini, P., Pavanetto, F., Spadaro, A., and Puglisi, G. 1997. Bioadhesive microspheres for ophthalmic administration of Acyclovir. J. Pharm. Pharmacol., 49: 737-742.
23. Ghezzo, E., Benedetti, L., Rochira, N., Biviano, F., and Callegaro, L. 1992. Hyaluronane derivative microsphere as NGF delivery device: Preparation methods and in vitro release characterisation. Int. J. Pharm., 87: 21-29.
24. Giunchedi, P., Juliano, C., Gavini, E., Cossu, M., and Sorrenti, M. 2002. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm., 53: 233-239.
25. Gooch, W.M., McLinn, S.E., Aronovitz, G.H., Pichichero, M.E., Kumar, A., Kaplan, E.L., and Ossi, M.J. 1993. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob. Agents Chemother., 37: 159-163.
26. Gouin, S. 2004. Microencapsulation: Industrial appraisal of existing technologies and trends. Trends Food Sci. Technol., 15: 330-347.
27. Harris, D. and Robinson, J.R. 1992. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci., 81: 1-10.
28. Hashimoto, Y., Tanaka, M., and Kishimoto, H. 2002. Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine. J. Pharm. Pharmacol., 54:1323-1328.
29. Hiroyuki, S., Hiraku, O., Yuri, T., Masanori, I., and Yoshiharu, M. 2003. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int. J. Pharm., 251: 123-132.
30. Hong, K., Khwaja, A., Liapi, E., Torbenson, M.S., Georgiades, C.S., and Geschwind, J.F. 2006. New intraarterial drug delivery system for the treatment of liver cancer: Preclinical assessment in a rabbit model of liver cancer. Clin. Cancer Res., 12: 2563-2567.
31. Illum, L. 1999. Bioadhesive formulations for nasal delivery. In E. Mathiowitz, D.E. Chickering, and C.M. Lehr (Eds.), Bioadhesive Drug Delivery Systems-Fundamentals, Novel Approaches and Development (pp. 519-539). New York, Marcel Dekker.
32. Illum, L. and Davis, S.S. 1987. Targeting of colloidal particles to the bone marrow. Life Sci., 40: 1553-1560.
33. Illum, L., Jorgensen, H., Bisgaard, H., Krogsgaard, O., and Rossing N. 1987. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm., 39: 189-199.
34. Ishikawa, T., Watanabe, Y., Utoguchi, N., and Matsumoto, M. 1999. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-tastemasked granules by the compression method. Chem. Pharm. Bull., 47: 1451-1454.
35. Jalil, R. and Nixon, J.R. 1989. Microencapsulation using poly(l-lactic acid). I: Microcapsule properties affected by the preparative technique. J. Microencapsul., 6: 473-484.
36. Jalil, R. and Nixon, J.R. 1990. Microencapsulation using poly (l-lactic acid) II: Preparative variables affecting microcapsule properties. J. Microencapsul., 7: 25-39.
37. Jianchen, X., Bovet, L.L., and Zhao, K. 2008. Taste masking microspheres for orally disintegrating tablets. Int. J. Pharm., 359: 63-69.
38. Kayumba, P.C., Huyghebaert, N., Cordella, C., Ntawukuliryayo, J.D., Vervaet, C., and Remon, J.P. 2007. Quinine sulphate pellets for flexible pediatric drug dosing: Formulation, development and evaluation of taste masking efficiency using the electronic tongue. Eur. J. Pharm. Biopharm., 66: 460-465.
39. Krauland, A.H., Guggi, D., and Bernkop-Schnurch, A. 2006. Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery. Int. J. Pharm., 307: 270-277.
40. Kyyronen, K., Hume, L., Benedetti, L., Urtti, A., Topp, E., and Stella, V. 1992. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: In vitro and in vivo release studies. Int. J. Pharm., 80:161-169.
41. Lieberman, A., Lachman, L., and Schwartz, J.B. 1989. Pharmaceutical Dosage Forms: Tablets (2nd ed., pp. 543-602). New York, Marcel Dekker.
42. Liu, W., Griffith, M., and Li, F. 2008. Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation. J. Mater. Sci. Mater. Med., 19: 3365-3371.
43. Lixin, W., Haibing, H., Xing, T., Ruiying, S., and Dawei, C. 2006. A less irritant norcantharidin lipid microsphere:Formulation and drug distribution. Int. J. Pharm., 323: 161-167.
44. Loftsson, T. and Masson, M. 2001. Cyclodextrins in topical drug formulations: Theory and practice. Int. J. Pharm., 225: 15-30.
45. Longer, M.A., Ch'ng, H.S., and Robinson, J.R. 1985. Bioadhesive polymers as platforms for oral controlled drug delivery. III. Oral delivery of chlorthiazide using a bioadhesive polymer. J. Pharm. Sci., 74:406-411.
46. Lu, J., Jackson, J.K., Gleave, M.E., and Burt, H.M. 2008. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother. Pharmacol., 61: 997-1005.
47. Lucinda-Silva, R.M. and Evangelista, R.C. 2003. Microspheres of alginate-chitosan containing isoniazid. J. Microencapsul., 20: 145-152.
48. Malmsten, M. (Ed.). 2002. Polymer particles. In Surfactants and Polymers in Drug Delivery (pp. 271-290). New York, Marcel Dekker.
49. Manoharan, C. and Singh, J. 2008. Insulin loaded PLGA microspheres: Effect of zinc salts on encapsulation, release, and stability. J. Pharm. Sci., 11: 675-681.
50. Mathiowitz, E., Jacob, J.S., Jong, Y.S., Carino, G.P., Chickering, D.E., Chaturvedi, P., Santos, C.A., Morrell, C., Bassett, M., and Vijayaraghavan, K. 1997. Biologically erodable microspheres as potential oral delivery systems. Nature, 386: 410-414.
51. Mehta, S.K., Dewan, R.K., and Bala, K. 1994. Percolation phenomenon and the study of conductivity, viscosity, and ultrasonic velocity in microemulsions. Phys. Rev. E. Stat. Phys. Plasmas Fluids Relat. Interdiscip. Top., 50: 4759-4762.
52. Nascimento, A., Laranjeira, M.C., Favere, V.T., and Josue, A. 2001. Impregnation and release of aspirin from chitosan/poly(acrylic acid) graft copolymer microspheres. J. Microencapsul., 18: 679-684.
53. Nii, T. and Ishii, F. 2005. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int. J. Pharm., 298: 198-205.
54. Passerini, N., Perissutti, B., Albertini, B., Voinovich, D., Moneghini, M., and Rodriguez, L. 2003. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J. Control. Release, 88: 263-275.
55. Powell, D.A., Nahata, M.C., Powell, N.E., and Ossi, M.J. 1991. The safety, efficacy, and tolerability of cefuroxime axetil suspension in infants and children receiving previous intravenous antibiotic therapy. Ann. Pharmacother., 25: 1236-1238.
56. Raghavendra, C.M., Namdev, B.Sh., Ajit, P.R., Sangamesh, A.P., and Tejraj, M.A. 2008. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohydr. Polym., 71: 42-53.
57. Rahman, Z., Kohli, K., Khar, R.K., Ali, M., Charoo, N.A., and Shamsher, A.A.A. 2006. Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech, 7(2): 1-7.
58. Rassu, G., Gavini, E., Spada, G., Giunchedi, P., and Marceddu, S. Ketoprofen spray-dried microspheres based on Eudragit (R) RS and RL: Study of the manufacturing parameters, Drug Development and Industrial Pharmacy vol. 34, iss. 11, pp. 1178-11877 (2008)
59. Richardson, J.L. and Armstrong, T.I. 1999. Vaginal delivery of calcitonin by hyaluronic acid formulations. In E. Mathiowitz, D.E. Chickering, and C.M. Lehr (Eds.), Bioadhesive Drug Delivery Systems-Fundamentals, Novel Approaches and Development (pp. 563-599). New York, Marcel Dekker.
60. Robson, H., Craig, D.Q.M., and Deutsch, D. 1999. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1. The influence of the choice of dissolution media on drug release. Int. J. Pharm., 190: 183-192.
61. Robson, H., Craig, D.Q.M., and Deutsch, D. 2000a. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release. Int. J. Pharm., 195: 137-145.
62. Robson, H., Craig, D.Q.M., and Deutsch, D. 2000b. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media. Int. J. Pharm., 201: 211-219.
63. Rokhade, A.P., Kulkarni, P.V., Mallikarjuna, N.N., and Aminabhavi, T.M. 2008. Preparation and characterization of novel semi interpenetrating polymer network hydrogel microspheres of chitosan and hydroxypropyl cellulose for controlled release of chlorothiazide. J. Microencapsul., 8: 1-10.
64. Saravanan, M., Anbu, J., Maharajan, G., and Pillai, K.S. 2008. Targeted delivery of diclofenac sodium via gelatin magnetic microspheres formulated for intra-arterial administration. J. Drug Target., 16: 366-378.
65. Seo, S.A., Khang, G., Rhee, J.M., Kim, J., and Lee, H.B. 2003. Study on in vitro release patterns of fentanylloaded PLGA microspheres. J. Microencapsul., 20: 569-579.
66. Shalit, I., Dagan, R., Engelhard, D., Ephros, M., and Cunningham, K. 1994. Cefuroxime efficacy in pneumonia:Sequential short-course iv: Oral suspension therapy. Israeli J. Med. Sci., 30: 684-689.
67. Shou, H. and Chen, L. 2002. Study on the methods of masking bitter taste of drugs. Shangdong Tradit. Med. J., 21: 302-304.
68. Sinha, V.R., Goyal, V., Bhinge, J.R., Mittal, B.R., and Trehan A. 2003. Diagnostic microspheres: An overview. Crit. Rev. Ther. Drug Carrier Syst., 20: 433-460.
69. Sinha, V.R. and Trehan, A. 2008. Development, characterization, and evaluation of ketorolac tromethamineloaded biodegradable microspheres as a depot system for parenteral delivery. Drug Deliv., 15: 365-372.
70. Sjoqvist, R., Graffeer, C., and Ekman, J. 1993. In vitro validation of the release rate and palatability of remoxipride-modified release suspension. Pharm. Res., 10: 1020-1030.
71. Soppimath, K.S., Kulkarni, A.R., and Aminabhavi, T.M. 2001. Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: Characterization and release kinetics of microspheres and tableted microspheres. J. Microencapsul., 18: 397-409.
72. Sveinsson, S.J., Kristmundsdottir, T., and Ingvarsdottir, K. 1993. The effect of tableting on the release characteristics of naproxen and ibuprofen microcapsules. Int. J. Pharm., 92: 29-34.
73. Thanoo, B.C., Sunny, M.C., and Jayakrishnan, A. 1992. Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol., 44:283-286.
74. Volkheimer, G. and Schultz, F.H. 1968. The phenomenon of persorption. Digestion, 1: 213-218.
75. Wang, J., Tabata, Y., and Moromoto, K. 2006. Aminated gelatin microspheres as a nasal delivery system for peptides drugs: Evaluation of in vitro release and in vivo insulin absorption in rats. J. Control. Release, 113: 31-37.
76. Yajima, T., Nogata, A., Demachi, M., Umeke, N., Itai, S., Yunoki, N., and Nemoto, M. 1996. Particle design for taste-masking using a spray congealing technique. Chem. Pharm. Bull., 44: 187-191.
77. Zhang, H., Lu, Y., Zhang, G., Gao, S., Sun, D., and Zhong, Y. 2008. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Int. J. Pharm., 351: 244-249.
78. Zhang, W., Jiang, X., Hu, J., and Fu, C. 2000. Rifampicin polylactic acid microspheres for lung targeting. J. Microencapsul., 17: 785-788.
79. Zhang, X.B. and Hou, X.P. 2003. Development of methods for masking unpleasant taste of drugs. Chin. Hosp. Pharm. J., 23: 43-45.